INTERK PEPTIDE THERAPEUTICS LTD has a total of 19 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV NEW YORK MEDICAL CT, EVOX THERAPEUTICS LTD and PENN MARC S.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 2 | |
#6 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Agrez Michael Valentine | 15 |
#2 | Agrez Michael | 3 |
#3 | Agrez Michael V | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020107079A1 | Polypeptides and methods for improving skin conditions | |
AU2019268411A1 | Activating agents | |
EP3794014A1 | Peptide activating agent | |
AU2018247561A1 | Compositions and methods for prophylaxis or treatment of pain | |
EP2807180A1 | Peptide agents for cancer therapy |